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Abstract
Background: A velocity-selective binomial excitation scheme for myocardial first-pass perfusion measurements with
hyperpolarized 13C substrates, which preserves bolus magnetization inside the blood pool, is presented. The
proposed method is evaluated against gadolinium-enhanced 1H measurements in-vivo.
Methods: The proposed excitation with an echo-planar imaging readout was implemented on a clinical CMR
system. Dynamic myocardial stress perfusion images were acquired in six healthy pigs after bolus injection of
hyperpolarized 13C urea with the velocity-selective vs. conventional excitation, as well as standard 1H gadolinium-
enhanced images. Signal-to-noise, contrast-to-noise (CNR) and homogeneity of semi-quantitative perfusion
measures were compared between methods based on first-pass signal-intensity time curves extracted from a mid-
ventricular slice. Diagnostic feasibility is demonstrated in a case of septal infarction.
Results: Velocity-selective excitation provides over three-fold reduction in blood pool signal with a two-fold
increase in myocardial CNR. Extracted first-pass perfusion curves reveal a significantly reduced variability of semi-
quantitative first-pass perfusion measures (12–20%) for velocity-selective excitation compared to conventional
excitation (28–93%), comparable to that of reference 1H gadolinium data (9–15%). Overall image quality appears
comparable between the velocity-selective hyperpolarized and gadolinium-enhanced imaging.
Conclusion: The feasibility of hyperpolarized 13C first-pass perfusion CMR has been demonstrated in swine.
Comparison with reference 1H gadolinium data revealed sufficient data quality and indicates the potential of
hyperpolarized perfusion imaging for human applications.
Keywords: Myocardial perfusion, First-pass perfusion, Hyperpolarization, 13C urea, Dynamic imaging
Background
Cardiovascular Magnetic Resonance (CMR) perfusion im-
aging is widely used for the clinical assessment of myocar-
dial ischemia and has proven its excellent diagnostic value
[1]. To increase the sensitivity and specificity of detecting
perfusion defects, imaging under pharmacologically in-
duced stress is performed, followed by an optional meas-
urement under rest condition [2]. In a clinical setting,
stress is typically induced by administration of adenosine
[3] or dobutamine [4].
Conventional first-pass perfusion CMR [5] is based on
dynamic contrast enhancement (DCE) of saturation recov-
ery [6] in response to bolus administration of a chelated
gadolinium based contrast agent. Due to the exponential
nature of spin-lattice relaxation and partial saturation ef-
fects of the image sequence itself, the relationship between
signal and contrast agent concentration is non-linear, which
renders the determination of actual contrast agent concen-
tration non-trivial [7]. Using dual-bolus [8] or dual-
sequences approaches [9] this issue can be addressed, but
adds to complexity of data acquisition and analysis.
Despite a long history of safe use of gadolinium contrast
agents in patients with normal kidney function, linear
gadolinium based contrast agents have recently come under
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scrutiny in the wake of reports of gadolinium accumulation
after repeated administration of certain types of agents
[10–12]. To this end, alternative methods to assess tissue
perfusion have attracted attention. Arterial spin labelling
(ASL) has been applied to the heart in experimental and
clinical settings [13]. Also, intra voxel incoherent motion
(IVIM) measurements have allowed assessing perfusion
fractions without the use of contrast agents [14–16]. How-
ever, both approaches provide limited contrast-to-noise ra-
tios (CNR) compared to contrast-enhanced first-pass
perfusion imaging and further research is required to trans-
late these methods into clinical use.
Dissolution dynamic nuclear polarization (DNP) allows
to produce solutions of highly polarized 13C–labeled mol-
ecules with >10′000-fold enhancement [17] relative to
thermal signal. To compensate for the low abundance of
carbon containing molecules in-vivo, a variety of endogen-
ous 13C–labeled DNP substrates have been used for in-
vivo imaging and spectroscopy studies, mostly probing
metabolic pathways and their pathologic alterations in
various organs and animal models [18]. Recently, first re-
sults of the application of hyperpolarized [1–13C] pyruvate
to measure cardiac metabolism in humans have been re-
ported [19].
Metabolically inert hyperpolarized substrates have
been suggested as alternative contrast agents for perfu-
sion measurements using DNP. HP001, a customized
non-endogenous substrate has been shown to enable
hyperpolarized perfusion assessment in rats [20]. En-
dogenous alternatives include the freely diffusible pre-
deuterated 2-methylpropan-2ol (tert-butanol) [21], as
well as α-trideuteromethyl [15N] glutamine with a par-
ticularly long T1 in-vivo [22]. Most prominently, 13C- la-
beled urea has been used to study perfusion in kidneys
[23–26], liver [27, 28] and tumors [20, 28] in rodent and
porcine models. In addition to qualitative assessments,
the linear dependency of signal intensity on substrate
concentration can simplify absolute blood flow quantifi-
cation under certain assumptions [29]. Simultaneous
probing of metabolism and perfusion with co-
polarization of metabolically active and inert substrates
may also improve diagnostic value by differentiation of
metabolic and perfusion defects [30].
The feasibility of myocardial perfusion imaging using
hyperpolarized 13C urea has recently been demonstrated
in rodents [31]. The particular anatomy of the heart poses
a major challenge: the close proximity of the myocardium
to the left ventricular (LV) and right ventricular (RV)
blood pools with comparatively high signal intensities
causes signal contamination at practically achievable
spatial resolutions. Accordingly, meaningful signal-
intensity time curves are only obtainable if the blood pool
signal is suppressed. To this end, flow-sensitizing gradi-
ents have been proposed to spoil signal contributions
from the non-stationary blood pool [31]. This approach,
however, depletes magnetization inside the blood pool,
which in turn limits the achievable signal-to-noise ratio
(SNR) inside the myocardium.
Dynamic metabolic imaging of hyperpolarized sub-
strates in the heart typically relies on spectral-spatial ex-
citation schemes, in which metabolites are excited
depending on their chemical shift [32, 33]. Downstream
metabolites are selectively excited with high flip angles,
while the input substrate in the blood pool experiences
reduced excitation angles. However, this approach is not
applicable for metabolically inert substrates with a single
resonance frequency, such as 13C urea.
In this work a velocity-selective tip-back excitation
that mitigates polarization saturation inside the blood
pool whilst retaining the suppression of blood pool sig-
nal is proposed. By integration of a bipolar velocity-
encoding gradient into slice selection of a binomial exci-
tation pulse, a velocity dependent phase shift in the
blood pool signal is introduced, which can be utilized to
preserve longitudinal magnetization in the blood pool.
The method is validated using phantom measurements
and the in-vivo applicability is demonstrated in swine.
Myocardial signal-intensity time curves obtained with
the proposed method are compared to conventional ex-
citation and clinically used gadolinium enhanced perfu-
sion CMR.
Methods
Sequence design
The accumulated phase φ of spins moving with velocity
v→ subject to a bipolar gradient pair with amplitude G
→ tð Þ
is dependent on the first gradient moment m
→
1:
φ ¼ γ m→1 ⋅ v!Þ

ð1Þ
With
m
→
1 ¼
Z
G
!
tð Þt dt
ð2Þ
As phase encoding only occurs along the gradient dir-
ection e ̂ G , a scalar notation of velocities as projections
of v ¼ v!⋅e ̂G is used in this manuscript.
When combined with a binomial 1–1 excitation
separated by the bipolar gradient pair, motion induced
phase accrual can be exploited to tip back the
magnetization of spins moving along the gradient dir-
ection by adjusting the excitation phase of the second
radio-frequency (RF) pulse.
Alternatively, the accumulated phase between excita-
tions for a given velocity venc can be set to π by scaling
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amplitude G(t) and duration T of the bipolar gradients
such that:
γ venc
Z T
0
G tð Þt dt ¼ π ð3Þ
This approach does not require adjustments of the
excitation phase for the second RF pulse with the
additional benefit of being relatively robust towards
small deviations from the nominal velocity venc. Sta-
tionary spins inside the myocardium that do not ac-
cumulate motion-dependent phase effectively undergo
two excitations, while the magnetization of moving
spins inside the left ventricular blood pool is retained
by tipping it back to the longitudinal axis by the sec-
ond RF excitation. This excitation can be combined
with any single-shot readout, such as echo-planar
(EPI) or spiral imaging.
For through-plane motion, which is predominant
for the left ventricular blood pool in short axis ac-
quisitions, the bipolar gradients can be efficiently in-
tegrated into the slice selection scheme as illustrated
in Fig. 1. Velocity components along other directions
than through-plane will not be affected by the
velocity-selective excitation and experience full exci-
tation instead. In cases where the predominating dir-
ection of blood flow is not perpendicular to the slice
orientation, the encoding gradients could be sepa-
rated from the slice selection gradients and applied
to different gradient axes at the cost of prolonged
echo times.
The effective excitation pattern for various venc
encodings as a function of through-plane velocity
over the imaging slice is illustrated in Fig. 2. For a
given venc encoding, the relative signal amplitude s in
dependency of the through-plane velocity v can be
determined as:
s vð Þ ¼ sin venc−ð vÞ
venc

π
2

j ð4Þ
Conversely, the amount of preserved magnetization
Mz in the blood pool can be estimated as:
Mz vð Þ ¼ cos ðvenc−vÞvenc

π
2

j ð5Þ
As the phase evolution is symmetric, the sign of the vel-
ocity and encoding gradients can be neglected. For the en-
coding velocity, the magnetization will be fully restored,
while deviations due to spatial flow variations or mis-
setting of the encoding velocity will result in imperfect
Fig. 1 Velocity-selective excitation scheme: Bipolar velocity encoding
gradients (dark grey) are incorporated into the slice selection gradients
of a 1–1 binomial excitation. The accumulated phase of moving spins
between the two RF pulses can be used to tip-back magnetization into
the longitudinal axis with the second RF pulse. The approach is similar
to spectrally selective binomial excitation, with the key difference that
phase is induced by velocity encoding gradients instead of chemical
shift variations of different molecules. The proposed excitation can be
combined with arbitrary single-shot sampling approaches, such as
echo-planar or spiral imaging
a
b
c
Fig. 2 Calculated excitation patterns for velocity-selective excitation,
relative to conventional single-pulse excitation. (a) effective excitation
patterns for various encoding strengths inside the LV blood pool.
Encoding of higher velocities yields a wider suppression band around
the nominal values. (b) zoomed-in view for velocity range typically
observed inside the myocardium (red box, a). For encoding strengths
>30 cm/s the myocardial signal is hardly affected (<10%). (c) echo-time
prolongation for velocity-selective excitation with respect to conventional
single-pulse excitation for various encoding strengths
Fuetterer et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:46 Page 3 of 12
tip-back and residual signal according to Eqs. 4 and 5 (see
Fig. 2a). It is therefore crucial that encoding velocities are
set to the specific mean systolic or diastolic velocity for
each subject, which can be obtained from phase contrast
pre-scans. Higher through-plane velocities in the LV blood
pool, with higher respective venc encodings, benefit from a
wider stop band around the target velocities (see Fig. 2a),
whilst reducing unwanted signal dampening inside the
slowly moving myocardium (see Fig. 2b). This makes the
proposed excitation especially suited for stress perfusion
measurements with increased blood velocities as pre-
sented in this work, but poses challenges for measure-
ments under rest conditions. Additionally, echo time (TE)
increases towards lower venc encodings, which limits the
maximum attainable signal due to T2* decay (see Fig. 2c).
The gap between the two RF pulses depends on encoding
strength and gradient hardware and ranged from 6.8 ms
(venc: 50 cm/s) to 8.4 ms (venc: 25 cm/s) on the clinical
CMR system used in this study.
CMR setup
All measurements were performed on a clinical 3 T Inge-
nia wide-bore scanner (Philips, Best, The Netherlands)
equipped with a gradient system delivering 30 mT/m
maximum amplitude at 200 T/m/s slew rate. Data on 13C
were acquired using a custom-made 4-channel transmit/
receive coil array (Clinical MR Solutions, Shadybrook, WI,
USA) while the 2-channel body coil was utilized to sample
on the 1H frequency. Animals were placed in right recum-
bency inside the scanner bore to allow for optimal place-
ment of the coil arrays. A peripheral pulse oximeter unit
was used for cardiac synchronization.
Hyperpolarization
A 6.4 M 13C urea glycerol solution was prepared and
doped with 18.5 mM AH111501 trityl radical. 1 mL sam-
ples were polarized for 4 h in a commercial 5 T SpinLab
Polarizer (General Electric Healthcare, Waukesha,
Wisconsin, USA) before dissolution using a buffer consist-
ing of 30 mL 0.1% EDTA dissolved in water. Upon sample
collection, the prepared solution was further diluted and
cooled down with additional 4.5 mL of buffer at 0 °C to
achieve body temperature for injection. 20 mL of the final
200 mM 13C urea solution were transferred to the scanner
using an electromagnetic carrier device [34] built in-
house, ensuring a magnetic field >7 mT over the whole
syringe volume and transport period (15–20 s).
Polarization levels were established in separate experi-
ments and amounted to 48 ± 5% at time of dissolution
and 29 ± 3% at time of injection. T1 relaxation times in-
side the 3 T magnet were measured for the neat solu-
tions (58 ± 1 s, n = 5) and after dilution in porcine
heparinized venous blood samples within 15 min after
sampling. Two urea concentrations (n = 5, each) were
measured: 10% and 33%, with an observed T1 of
25 ± 2 s and 34 ± 0.5 s, respectively.
Phantom validation
The proposed excitation scheme was validated using 1H
imaging of a water tube embedded in a solid gel phan-
tom. Water flow was adjusted to ~50 cm/s, which is in
accordance with LV velocities typically observed in-vivo.
A single 2D slice perpendicular to the direction of flow
was acquired using a single-shot EPI readout. Signals in-
side the water tube as well as the stationary gel region
were compared to simulations for the conventional
single-pulse and the proposed tip-back excitation with
varying venc encodings. All measurements were normal-
ized to the water signal of the conventional excitation.
Animal handling
Seven healthy female swine (Edelschwein, weight 30–35 kg)
were used for the experiments. All swine were premedi-
cated, intubated and sheaths (5 F) were introduced into both
femoral arteries and veins. 100 IU/kgBW Heparin was given
intravenously and repeated every hour. General anesthesia
was maintained with isoflurane (2% - 3%) by positive pres-
sure ventilation with 100% oxygen. Heart rate and rhythm
and variability (ECG), inspiratory and expiratory gases (CO2,
O2, isoflurane), pulse oximetry, temperature, direct arterial
blood pressure, urine output, and arterial and venous blood
gases were monitored continuously throughout the proced-
ure. Hyperpolarized 13C urea and 1H gadolinium were ad-
ministered through separate catheters in the femoral veins.
Cardiac stress was pharmacologically induced by intra-
venous administration of dobutamine (Dobutrex, TEVA
Pharma AG, Basel, Switzerland) at increasing infusion
rates until the target heart rate of 120 bpm was reached.
Upon reaching the target heart rate, infusion rates were
kept constant during all imaging experiments. 20 mL of
hyperpolarized 13C urea solution was injected as a bolus
at a rate of 10 mL/s. No adverse effects were observed as a
result of 13C urea injections.
In one animal, acute myocardial infarction in the apical
septum was induced by permanent distal ligation of the
left anterior descending coronary artery (LAD). Corre-
sponding data was not included in the main analysis of
this study, but used as demonstration of sensitivity of the
proposed excitation scheme to detect ischemic myocar-
dium. After the procedure, all animals were euthanized in
deep anesthesia by lethal injection of pentobarbital.
In-vivo measurements
Prior to each 13C measurement, 1H phase-contrast images
were acquired using a 2D short-axis cine sequence under
stress condition. Sequence parameters were:
FOV = 250 × 220 mm2, slice thickness 8 mm, in-plane
resolution 2.5 × 2.5 mm2, TR = 4.8 ms, TE = 2.8 ms, FA = 7°,
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cardiac phases = 35, venc = 100 cm/s. These short-axis cine
images were used to determine through-plane velocities
and trigger delays for subsequent 13C perfusion CMR.
Anatomical reference 2D cine short-axis CMR was
performed using a balanced steady-state free precession
gradient echo sequence with the following parameters:
FOV = 350 × 280 mm2, slice thickness 8 mm, in-plane
resolution 1.9 × 1.9 mm2, TR = 2.7 ms, TE = 1.35 ms,
FA = 45°, cardiac phases = 60.
Dynamic series of 13C perfusion images were acquired
with cardiac triggering starting seven heart beats after the
start of injection to minimize bolus saturation in the RV
blood pool. Ventilation was suspended for the first 45 s of
imaging to avoid misregistration between individual time
frames. The proposed 1–1 binomial tip-back excitation
(FA: 2 × 30°) was compared to single-pulse excitation (FA:
60°) in each animal under maintained stress condition
with two hyperpolarized bolus injections, separated by
10 min. Identical single-shot echo planar imaging readouts
were employed in both cases with following parameters:
FOV = 110 × 110 mm2, slice thickness 15 mm, in-plane
resolution 3.0 × 3.0 mm2, TR = 1 heartbeat, partial Fourier
factor 0.65, readout duration 32 ms. Effective echo times
for the proposed excitation increased from TE = 10.2 ms
(conventional) to TE = 13.3–14.2 ms in dependence of
flow encoding as illustrated in Fig. 2c. Encoding strengths
(venc) between 25 cm/s and 52 cm/s (mean ± std.:
38 ± 7 cm/s) for the velocity-selective excitation were used
based on measured through-plane velocities.
Conventional 1H gadolinium contrast-enhanced per-
fusion CMR under stress was performed as a reference
method in each animal. A dose of 0.1 mmol/kg gadolin-
ium (Gadovist 1.0, Bayer, Zurich, Switzerland), followed
by a 30 mL saline flush was injected at a rate of 4 mL/s
using a power injector (Medrad, Indianola, PA, USA).
Dynamic image series were acquired every heart beat
using a saturation-recovery spoiled gradient echo se-
quence with parameters: FOV = 220 × 210 mm2, slice
thickness 10 mm, in-plane resolution 3.0 × 3.0 mm2,
TR = 1.9 ms, TE = 0.7 ms, FA = 15°, WET saturation
[35] delay = 100 ms. A total of 100 dynamics were ac-
quired during suspended ventilation.
Image reconstruction
All in-vivo images were reconstructed from raw data
using MRecon (GyroTools LLC, Zurich, Switzerland)
and zero-filled to a common resolution of 1 × 1 mm2.
1H images were then rotated, aligned and cropped to the
FOV of the 13C images. Nyquist-ghosts of the EPI read-
out were removed by first order phase correction maxi-
mizing signal intensity in a predefined region of interest
(e.g. LV blood pool). 13C coil combination was imple-
mented as root of weighted sum of squares [36].
Post-processing
Left ventricular myocardium and LV blood pool were
manually segmented on overlays of 13C perfusion and
1H reference images. The myocardium was subse-
quently divided into six segments corresponding to
the basal/mid-ventricular slices in the 16 segment
AHA model [37].
Coil sensitivities were estimated and corrected by fit-
ting a plane over the myocardial signal at a time frame
prior to and after bolus passage for 1H and 13C scans,
respectively.
13C urea signal intensities were calculated as mean
values over each segment and the LV blood pool. Global
magnitude offsets were corrected for by subtraction of
mean noise levels of the last 10 time frames in the image
series.
Three-parameter gamma-variate functions
s tð Þ ¼ a tb e−tc ð6Þ
were fitted to the signal time curves s(t) for further data
analysis of 13C urea data. 1H gadolinium time curves
were fitted with fourth order polynomials respectively.
Area under the curve (AUC), peak myocardial contrast-
to-noise ratio (pCNR) and up-slope were extracted from
the fitted curves as semi-quantitative perfusion measures
for 13C urea and 1H contrast-enhanced scans [7].
Signal-to-noise ratio (SNR) was calculated as mean
signal intensities divided by the standard deviation
over the difference of two noise frames pre (1H) or
post (13C) bolus [38]. CNR was calculated as differ-
ences of peak contrast-enhanced SNR and mean base-
line SNR as described in [39].
Absolute values and variability over the six myocardial
segments were compared between conventional and the
proposed tip-back excitation, as well as to 1H gadolin-
ium based measurements. Analysis was restricted to
first-pass signal contributions in all cases. Coefficients of
variance (CoV) were calculated as standard deviation di-
vided by mean values. A paired, two-sided Wilcoxon
signed rank test was employed for statistical compari-
sons. A p-value <0.05 was considered significant.
Results
Phantom experiments
Figure 3 illustrates measured signal intensities of the pro-
posed and conventional excitation in a phantom with con-
stant flow of 48 cm/s in comparison to simulations.
Variations in venc encoding strength show good agreement
with the predicted signal overall. Encoding with the nom-
inal velocity (48 cm/s) yields a > 80% reduction in water
signal. Residual signal is observed at the tube boundary,
where velocities deviate from the nominal value. Encoding
with approximately half the nominal velocity (25 cm/s),
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which results in an accumulated phase of 2π, recovers
78% of the signal as expected due to inflow effects, stron-
ger T2* weighting of the prolonged excitation and finite
sharpness of the velocity distribution.
In-vivo experiments
Figure 4a shows measured through-plane velocities over the
cardiac cycle in short axis orientation under dobutamine
stress. Variability of blood velocities between ejection phase
(35 cm/s) and filling phase (− 42 cm/s) is observed in con-
trast to minor variations inside the myocardium (≤ 7 cm/s).
The velocity difference between LV blood pool and myocar-
dium is particularly pronounced in early systole and early
diastole. Figure 4b illustrates the distributions of measured
through-plane velocities of myocardium (−0.82 ± 5.2 cm/s)
and LV blood pool (33.4 ± 6.2 cm/s) in early systole with
the overlaid excitation pattern. Myocardial tissue gets ex-
cited with a relative amplitude >0.9, the LV blood pool with
a relative amplitude <0.4 (within one standard deviation of
the respective mean velocities). Preserved magnetization in
the LV blood pool was estimated as 93 ± 4% over all sub-
jects, based on spatial integration of Eq. 5. Saturation from
sideband effects and blood exchange during excitation were
considered negligible under in-vivo conditions.
In Fig. 5, a comparison of dynamic image series of
myocardial bolus passage for 13C urea conventional exci-
tation, 13C urea velocity-selective excitation and 1H
gadolinium based contrast agent is shown. During LV
bolus peak at 2 s (second column), blood pool signal
suppression is apparent for the velocity-selective in con-
trast to conventional excitation. Residual LV signal stems
from low blood flow near the trabeculae. Myocardial
bolus signal (4–6 s) is significantly enhanced for the pro-
posed method, with a clear distinction of right and left
ventricular myocardium.
Figure 6 provides representative signal-time curves ex-
tracted from a six-sector AHA segmentation for 1H gado-
linium (Gd), 13C velocity-selective (VS) and 13C
conventional (C) measurements. Mean myocardial SNR av-
eraged over each sector was 18.4 ± 1.5 (Gd), 25.7 ± 2.6
(VS) and 15.1 ± 2.5 (C), respectively.
For conventional excitation, blood pool spillover in
the septal sectors 1 and 2, as well as the lateral sec-
tor 5 is observed. Myocardial peak signal appears at
an unphysiologically early time point with respect to
the LV peak bolus. Velocity-selective excitation yields
uncontaminated myocardial response curves with
good homogeneity over the six sectors. Myocardial
peak signal is observed at the physiologically ex-
pected time point 2–3 s after the LV blood pool sig-
nal peak. Up-slope, timing and homogeneity are
comparable with signal curves obtained from
gadolinium-enhanced measurements.
Intramyocardial coefficients of variance of semi-
quantitative perfusion measures over six animals are evalu-
ated for six animals in Fig. 7a. The variability of peak myo-
cardial CNR is ≤20% for the three sequences (9 ± 5% (Gd),
12 ± 3% (VS), 20 ± 5% (C)). AUC variability is significantly
(P = 0.03) higher for conventional excitation (47 ± 53%)
compared to 1H gadolinium (12 ± 6%) and velocity-
selective excitation (14 ± 4%). Upslope variability shows the
largest inter-sequence discrepancy: 15 ± 5% (Gd), 20 ± 9%
(VS), 93 ± 61% (C).
Peak SNR of LV blood pool is significantly (P = 0.03)
lower for velocity-selective excitation (149 ± 117) com-
pared to conventional excitation (473 ± 125), as illus-
trated in Fig. 7b.
Absolute myocardial peak CNR values are shown in
Fig. 7c. The proposed excitation scheme shows a
more than two-fold CNR increase compared to 1H
gadolinium (19.2 ± 3.7 vs. 9.6 ± 3.9), and a significant
(P = 0.03) increase compared to conventional excita-
tion (9.5 ± 3.5).
Acute infarction
In Fig. 8 the feasibility of the proposed method to detect
perfusion defects is demonstrated. In this case reduced
septal perfusion is seen in both 13C velocity-selective
Fig. 3 Phantom validation in 1H gel phantom around water pipe with
mean flow velocity of 48 cm/s. (top row) Images acquired using a
conventional single-pulse excitation (left), the proposed velocity-selective
binomial excitation at nominal encoding strength (center) and half the
nominal encoding velocity (right). (bottom) Measured vs. simulated signal
intensities in static and flow compartments for varying velocity
encodings. Data points corresponding to the top images are highlighted
in dashed circles. Measured signal intensities overall match the predictions
with maximum deviations of 20%. At nominal velocity encoding, residual
signal stems from the low velocity regime at the boundary of the tube
(see also Fig. 4). Encoding with half the nominal velocity restores most of
the signal due to an accumulated phase of 2π. Deviations from nominal
velocity and stronger T2* weighting for smaller venc values prohibit
perfect recovery of magnetization in measurements
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and 1H gadolinium-enhanced images. Extracted myocar-
dial perfusion curves confirm the perfusion defect in
AHA sector 2 in both datasets. Increased LV signal spill-
over is detected for the urea measurement.
Discussion
In this study, the feasibility of hyperpolarized myocar-
dial first-pass perfusion CMR using velocity-selective
excitation was demonstrated. Significantly enhanced
SNR and CNR compared to conventional excitation
(P < 0.05), as well as good discrimination of LV blood
pool signal have been shown. Direct comparison with
1H gadolinium data indicates that the proposed
method can produce sufficient data quality for diag-
nostic purposes in large subjects.
Comparison of velocity-selective 13C urea and 1H
gadolinium measurements revealed good agreement
between both methods. The signal enhancement
during the myocardial first-pass showed similar pat-
terns with respect to relative timing and signal ampli-
tudes. Differences in signal-time curves were
associated with differences in contrast agent charac-
teristics. While gadolinium based agents showed a
second bolus pass, the hyperpolarized signal vanished
after the first-pass due to polarization decay and
quenching by excitation. Accordingly, there was no
baseline signal enhancement remaining at the end of
the measurement, hence allowing individual hyperpo-
larized measurements to be performed in rapid suc-
cession, whereas gadolinium based contrast agents
require a washout period. CNR and signal homogen-
eity of 13C urea imaging appeared to be sufficient for
detecting perfusion defects as demonstrated in the is-
chemia example.
1H gadolinium measurements were performed using a
relatively high contrast agent dose of 0.1 mmol/kg,
a
b
Fig. 4 (a) measured through-plane velocities under dobutamine stress (120 bpm) over the cardiac cycle for left ventricular myocardium and blood
pool. Mean and standard deviation over the respectively segmented areas are presented. Contrast of the proposed excitation is based on velocity
differences between tissue and blood as highlighted in grey. Early systole (red box) and early diastole are therefore especially suited heart phases
for the proposed method. (b) histogram of velocity distributions inside LV myocardium and blood pool in early systole (red box, top plot). Mean
and standard deviation over both compartments are overlaid in black. Relative excitation amplitudes for encoding with the mean velocity inside
the LV blood pool are shown in red. Blood pool signal is strongly suppressed whilst myocardial signal is largely retained
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which is at the upper end of clinical administration for
qualitative and quantitative perfusion CMR. Despite this
CNR-optimal dose, the average peak myocardial CNR
was 50% lower than in velocity-selective 13C urea
measurements.
Perfusion CMR in this study was limited to acquisitions
under stress condition, while clinical protocols often in-
clude an optional reference measurement under rest condi-
tion. Precursor stages of coronary artery disease, however,
are only detectable under increased myocardial workload
[4], which gives stress perfusion a higher diagnostic value.
Nonetheless, rest perfusion is required for the calculation
of perfusion reserve as a semi-quantitative marker for myo-
cardial ischemia that is widely used in clinical diagnostics
[40]. Absolute quantification of myocardial blood flow
(MBF) is a way of mitigating the need for additional mea-
surements under rest conditions, whilst providing quantita-
tive physiological parameters.
Due to limitations in scanner hardware, 1H gadolinium
measurements had to be performed with the 2-channel
body coil as a receiver, while a 4-channel surface coil
was used for 13C urea detection. Consequently, image
quality of 1H gadolinium data in this work was lower
than in a standard perfusion CMR setup. A two-fold in-
crease in SNR and 1.5-fold increase in CNR is estimated
for measurements with a dedicated 28 channel cardiac
coil array based on previous experiments. To this end, a
dedicated 1H/13C receiver array will be commissioned to
allow for improved 1H/13C signal detection in the future.
With the velocity-selective excitation scheme, the en-
coding gradients can in principle be scaled to any blood
velocity. However, excitation profiles become narrower
with lower velocities (see Fig. 2a), while measured vel-
ocity distributions remain relatively broad. This effect
leads to a reduced effectiveness of the method under rest
condition. Higher order velocity encoding could be used
to broaden the suppression band of the excitation pat-
terns in these cases. The efficacy of this approach given
the necessary echo time prolongation needs to be inves-
tigated. During rest, the imaging window is meanwhile
restricted to diastole, where rapid inflow of blood at
>20 cm/s occurs. Preliminary acquired diastolic images
appear sufficient for visual assessment of perfusion de-
fects, however, the extraction of signal-intensity time
curves is challenging due to the relatively thin myocar-
dium (see Additional file 1: Figure S1).
Given a minimum TR < 50 ms, multiple slices
within one cardiac cycle can be acquired. Depending
on the number of slices and their distribution over
the cardiac cycle, velocity encoding needs to be ad-
justed for each slice based on flow measurements at
the respective heart phase (see Fig. 4b). While basal
a
b
c
Fig. 5 Dynamically enhanced cardiac perfusion imaging series covering bolus passage in LV blood pool and myocardium. (a) 13C urea conventional
excitation. (b) 13C urea velocity-selective excitation. (c) 1H gadolinium based contrast agent. Image series were sequentially acquired in one animal
under maintained stress conditioning. Myocardial bolus peak occurs between 4 and 6 s after injection (see Fig. 6). Left anterior descending coronary
artery (LAD) is indicated by red arrow. LV blood pool is visualized by the red contour
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and mid-ventricular slices are well suited for velocity-
selective excitation, acquisitions of apical slices remain
challenging due to low through-plane velocities of
blood in the apex. In order to utilize the radial blood
flow pattern in the apical region, encoding along
lateral directions might prove beneficial in this case.
Encoding along directions orthogonal to the slice se-
lection direction however results in additional echo
time prolongation, as the encoding gradients must be
separated from the slice selection gradients.
a
c
b
d
Fig. 6 Representative comparison of perfusion curves extracted from a 6 sector AHA segmentation (a). Measurements were obtained within the
same maintained dobutamine administration in the same animal for: (b) 13C urea conventional excitation. (c) 13C urea velocity selective excitation.
(d) 1H gadolinium. Myocardial response data is presented as measured (markers) and fitted (lines). Arterial input data (red) is downscaled by
factors 5 or 20 for better visualization. Gamma-variate fitting was employed for input curves and 13C urea response, 4th order polynomials were
used for 1H gadolinium response
a b c
Fig. 7 Analysis of semi-quantitative myocardial perfusion measures (pCNR, AUC, upslope) extracted from 6 sector AHA segmentation in six
animals. 1H gadolinium, 13C urea velocity-selective excitation and 13C urea conventional excitation measurements were performed for each animal
during maintained dobutamine administration. (a) Coefficient of Variance of semi-quantitative perfusion measures over the 6 myocardial AHA
sectors (mean +/− std). (b) Absolute peak SNR of LV blood pool signal. (c) Absolute peak myocardial contrast-to-noise ratio for each modality
(mean +/− std). n.s.: not significant, *: P < 0.05
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Alternatively, encoding gradients may be adjusted to
encode acceleration [41] in conjunction with a higher
order binomial excitation. Despite the apparent echo
time penalty, this approach could enable imaging in
more heart phases and regions with non-uniform flow
patterns such as the apex.
To maximize the efficacy of the proposed method,
the bipolar gradient pair should be aligned with the
predominant flow direction within the LV blood pool
(basal to apical). Short axis acquisitions are therefore
especially suited, as the encoding gradients can be
partly integrated into slice selection gradients without
echo time penalty. Nevertheless, the encoding gradi-
ents can be applied along directions other than the
slice selection direction for applications where differ-
ent slice orientations (e.g. long axis) are required. In
addition to an echo time penalty from temporal gra-
dient separation, this approach would also require an
additional bipolar gradient along the slice selection
direction to compensate for the phase accrual gener-
ated by the binomial excitation. The feasibility and ef-
ficacy of such an approach remain to be investigated.
Related to our work, the use of flow sensitizing gradi-
ents for the suppression of LV blood pool signal has pre-
viously been proposed [31]. In contrast to the signal
dephasing of moving spins as in [31], the velocity-
selective excitation proposed here has several advan-
tages. Firstly, the magnetization inside the blood pool is
preserved, which prevents pre-saturation of the hyperpo-
larized substrate bolus before its arrival in the myocar-
dium. Consequently, large flip angles >45° can be
applied to maximize signal in the first bolus passage.
Secondly, dephasing the blood pool signal by means of
bipolar gradients requires large first gradient moments,
which also compromise myocardial signal.
As an alternative to the single-shot EPI readout used
in this work, spiral k-space trajectories may be employed
[30, 31, 42, 43]. However, the limited gradient perform-
ance of typical clinical systems renders sufficient in-
plane resolution at reasonable field of views in large ani-
mals and humans challenging.
Qualitative and semi-quantitative perfusion CMR, as cov-
ered by this work, is diagnostically valuable for the detec-
tion of local ischemia. To reduce operator dependence
during analysis and to enable the detection of absolute
changes in perfusion, myocardial blood flow (MBF) quanti-
fication is preferred [7]. However, the determination of ac-
curate arterial input functions from measured signals
requires models of varying complexity [40, 44] and appro-
priate treatment of baseline signals. Hyperpolarized meta-
bolically inactive substrates may present an advantage as
the agent concentration is directly proportional to the
a
b
Fig. 8 Stress perfusion measurements with septal infarction induced by permanent ligation of the distal anterior descending coronary artery. (left)
Sum over three time frames at myocardial bolus peak. (right) corresponding perfusion curves for six AHA segments. Perfusion defect is visually
observed in septal wall (blue arrow) and time curves of sector 2 (blue curve) for both modalities. LV signal spillover in the 13C urea perfusion
curves stems from thinned myocardium in the infarct region. At myocardial bolus passage, the infarcted region shows strongly reduced signal.
LAD is not detectable in either modality due to ligation. (a) 13C urea velocity-selective excitation. (b) 1H gadolinium based contrast agent
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measured signal upon correction for T1 decay and flip
angle. Absolute perfusion quantification using hyperpolar-
ized 13C substrates has been demonstrated in cancer, brain
and kidneys [20, 28, 45]. These approaches are, however,
not directly applicable to MBF quantification, as the myo-
cardial response is affected by bolus saturation inside the
blood pool. Future studies will combine velocity-selective
imaging of the heart with interleaved sampling of the arter-
ial input to address these issues.
Conclusion
A velocity-selective excitation scheme for first-pass myo-
cardial perfusion measurements using hyperpolarized
13C urea has been presented. Direct comparison with 1H
gadolinium measurements showed very good agreement,
indicating the potential of hyperpolarized 13C urea
perfusion imaging for diagnostic purposes.
Additional file
Additional file 1: Figure S1. Dynamically enhanced cardiac perfusion
imaging series acquired under rest condition (heart rate = 90 bpm) in
diastole using hyperpolarized 13C urea and velocity-selective excitation
(venc = 25 cm/s). Myocardial bolus peak under rest condition is delayed
by approximately 2 s compared with stress measurements due to lower
heart rates. (PDF 517 kb)
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